200 related articles for article (PubMed ID: 32084139)
1. Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer.
Judge SJ; Yanagisawa M; Sturgill IR; Bateni SB; Gingrich AA; Foltz JA; Lee DA; Modiano JF; Monjazeb AM; Culp WTN; Rebhun RB; Murphy WJ; Kent MS; Canter RJ
PLoS One; 2020; 15(2):e0224775. PubMed ID: 32084139
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.
Canter RJ; Grossenbacher SK; Foltz JA; Sturgill IR; Park JS; Luna JI; Kent MS; Culp WTN; Chen M; Modiano JF; Monjazeb AM; Lee DA; Murphy WJ
J Immunother Cancer; 2017 Dec; 5(1):98. PubMed ID: 29254507
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.
Razmara AM; Farley LE; Harris RM; Judge SJ; Lammers M; Iranpur KR; Johnson EG; Dunai C; Murphy WJ; Brown CT; Rebhun RB; Kent MS; Canter RJ
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631708
[TBL] [Abstract][Full Text] [Related]
4. Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target.
Gingrich AA; Reiter TE; Judge SJ; York D; Yanagisawa M; Razmara A; Sturgill I; Basmaci UN; Brady RV; Stoffel K; Murphy WJ; Rebhun RB; Brown CT; Canter RJ
Front Immunol; 2021; 12():670309. PubMed ID: 34594320
[TBL] [Abstract][Full Text] [Related]
5. Association of Canine Osteosarcoma and Monocyte Phenotype and Chemotactic Function.
Tuohy JL; Lascelles BD; Griffith EH; Fogle JE
J Vet Intern Med; 2016 Jul; 30(4):1167-78. PubMed ID: 27338235
[TBL] [Abstract][Full Text] [Related]
6. Palliative radiation therapy for canine osteosarcoma.
Mayer MN; Grier CK
Can Vet J; 2006 Jul; 47(7):707-9. PubMed ID: 16898117
[No Abstract] [Full Text] [Related]
7. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer.
Choi JW; Lee ES; Kim SY; Park SI; Oh S; Kang JH; Ryu HA; Lee S
BMC Cancer; 2019 Aug; 19(1):817. PubMed ID: 31426763
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy for canine appendicular osteosarcoma.
Coomer A; Farese J; Milner R; Liptak J; Bacon N; Lurie D
Vet Comp Oncol; 2009 Mar; 7(1):15-27. PubMed ID: 19222827
[TBL] [Abstract][Full Text] [Related]
9. Four fraction palliative radiotherapy for osteosarcoma in 24 dogs.
Green EM; Adams WM; Forrest LJ
J Am Anim Hosp Assoc; 2002; 38(5):445-51. PubMed ID: 12220029
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
[TBL] [Abstract][Full Text] [Related]
11. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
[TBL] [Abstract][Full Text] [Related]
12. Autologous cancer cell vaccination, adoptive T-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcoma.
Flesner BK; Wood GW; Gayheart-Walsten P; Sonderegger FL; Henry CJ; Tate DJ; Bechtel SM; Donnelly LL; Johnson GC; Kim DY; Wahaus TA; Bryan JN; Reyes N
J Vet Intern Med; 2020 Sep; 34(5):2056-2067. PubMed ID: 32649801
[TBL] [Abstract][Full Text] [Related]
13. NCR1 is an activating receptor expressed on a subset of canine NK cells.
Grøndahl-Rosado C; Boysen P; Johansen GM; Brun-Hansen H; Storset AK
Vet Immunol Immunopathol; 2016 Sep; 177():7-15. PubMed ID: 27436439
[TBL] [Abstract][Full Text] [Related]
14. Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs.
Wright T; Brisson BA; Wood GA; Oblak M; Mutsaers AJ; Sabine V; Skowronski K; Belanger C; Tiessen A; Bienzle D
Cytometry A; 2019 Sep; 95(9):997-1007. PubMed ID: 31282052
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3
Lee SH; Shin DJ; Kim Y; Kim CJ; Lee JJ; Yoon MS; Uong TNT; Yu D; Jung JY; Cho D; Jung BG; Kim SK; Suh GH
Front Immunol; 2018; 9():841. PubMed ID: 29755462
[TBL] [Abstract][Full Text] [Related]
16. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells.
Marafini I; Monteleone I; Di Fusco D; Sedda S; Cupi ML; Fina D; Paoluzi AO; Pallone F; Monteleone G
PLoS One; 2016; 11(5):e0155103. PubMed ID: 27171408
[TBL] [Abstract][Full Text] [Related]
17. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
[TBL] [Abstract][Full Text] [Related]
18. The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy.
Oblak ML; Boston SE; Higginson G; Patten SG; Monteith GJ; Woods JP
Vet Surg; 2012 Apr; 41(3):430-5. PubMed ID: 23253085
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.
Yang HG; Kang MC; Kim TY; Hwang I; Jin HT; Sung YC; Eom KS; Kim SW
J Immunother Cancer; 2019 May; 7(1):138. PubMed ID: 31126350
[TBL] [Abstract][Full Text] [Related]
20. Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs.
Duffy ME; Anderson CL; Choy K; Fidel JL
Can Vet J; 2018 Feb; 59(2):136-142. PubMed ID: 29386671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]